Response to: 'Calprotectin is not independent from baseline erosion in predicting radiological progression in early rheumatoid arthritis' by Chevreau
et al
Ann Rheum Dis
.
2018 Dec;77(12):e85.
doi: 10.1136/annrheumdis-2017-212869.
Epub 2018 Jan 10.
Authors
Maria Karolina Jonsson
1
2
,
Nina Paulshus Sundlisæter
2
,
Hilde Haugedal Nordal
1
3
,
Hilde Berner Hammer
2
,
Anna-Birgitte Aga
2
,
Désirée van der Heijde
2
4
,
Tore Kristian Kvien
2
,
Bjørg-Tilde Svanes Fevang
1
3
,
Siri Lillegraven
2
,
Espen Andre Haavardsholm
2
5
Affiliations
1
Bergen Group of Epidemiology and Biomarkers in Rheumatic Disease, Department of Rheumatology, Haukeland University Hospital, Bergen, Norway.
2
Department of Rheumatology, Diakonhjemmet Hospital, Oslo, Norway.
3
Broegelmann Research Laboratory, Department of Clinical Science, University of Bergen, Bergen, Norway.
4
Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
5
Institute of Health and Society, University of Oslo, Oslo, Norway.
PMID:
29321158
DOI:
10.1136/annrheumdis-2017-212869
No abstract available
Keywords:
disease activity; rheumatoid arthritis; treatment.
Publication types
Letter
Comment
MeSH terms
Arthritis, Rheumatoid*
Disease Progression
Humans
Inflammation
Leukocyte L1 Antigen Complex*
Radiography
Substances
Leukocyte L1 Antigen Complex